Methods and kits for predicting a response to an erythropoietic agent

Merchant, Michael L.; Klein, Jon B.; Brier, Michael E.; Gaweda, Adam E.

Title: Methods and kits for predicting a response to an erythropoietic agent

Patent · Tue Jun 16 00:00:00 EDT 2015

OSTI ID:1184560

Merchant, Michael L.; Klein, Jon B.; Brier, Michael E.; Gaweda, Adam E.

Methods for predicting a response to an erythropoietic agent in a subject include providing a biological sample from the subject, and determining an amount in the sample of at least one peptide selected from the group consisting of SEQ ID NOS: 1-17. If there is a measurable difference in the amount of the at least one peptide in the sample, when compared to a control level of the same peptide, the subject is then predicted to have a good response or a poor response to the erythropoietic agent. Kits for predicting a response to an erythropoietic agent are further provided and include one or more antibodies, or fragments thereof, that specifically recognize a peptide of SEQ ID NOS: 1-17.

View Patent

Cite

Export

Save

Research Organization:: University of Louisville Research Foundation, Inc., Louisville, KY (United States)

Sponsoring Organization:: USDOE

DOE Contract Number:: FG02-05ER64060

Assignee:: University of Louisville Research Foundation, Inc. (Louisville, KY)

Patent Number(s):: 9,057,731

Application Number:: 13/167,478

OSTI ID:: 1184560

Country of Publication:: United States

Language:: English

References (30)

Method for automatic dosing of drugs Jacobsen, Stephen C.; Zentner, Gaylen M. https://doi.org/https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/6056734 US Patent Document 6,056,734	patent	May 2000
Method and system for use in treating a patient with any drug to optimize therapy and prevent an adverse drug McMichael, John https://doi.org/https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/6267116 US Patent Document 6,267,116	patent	July 2001
Method and apparatus for use in treating a patient with any drug to optimize therapy and prevent an adverse drug McMichael, John https://doi.org/https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/6575169 US Patent Document 6,575,169	patent	June 2003
Neural network drug dosage estimation Tang, Sharon S.; Diamond, Cornelius; Arouh, Scott https://doi.org/https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/6658396 US Patent Document 6,658,396	patent	December 2003
Pharmacokinetic and pharmacodynamic modeling of erythropoietin administration Cheung, Wing; Gibson, David Richard; Cote, Christine https://doi.org/https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/6747002 US Patent Document 6,747,002	patent	June 2004
Systems and methods for medication monitoring Vrijens, Bernard; Urquhart, John; De Klerk, Erik https://doi.org/https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/6822554 US Patent Document 6,822,554	patent	November 2004
Method and apparatus for dosing single and multi-agent therapy McMichael, John https://doi.org/https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/6883521 US Patent Document 6,883,521	patent	April 2005
Erythropoietin dosing regimen for treating anemia Farrell, Francis; Jolliffe, Linda https://doi.org/https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7232797 US Patent Document 7,232,797	patent	June 2007
Method and apparatus for glucose control and insulin dosing for diabetics Doyle, III, Francis J.; Jovanovic, Lois https://doi.org/https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7651845 US Patent Document 7,651,845	patent	January 2010
Erythropoietic therapy for the treatment of anemia in patients with cancer: a valuable clinical and economic option Cornes, Paul; Coiffier, Bertrand; Zambrowski, Jean-Jacques Current Medical Research and Opinion, Vol. 23, Issue 2, p. 357-368 https://doi.org/10.1185/030079906X167282	journal	December 2006
Anemia of inflammation: the cytokine-hepcidin link Andrews, Nancy C. Journal of Clinical Investigation, Vol. 113, Issue 9 https://doi.org/10.1172/JCI200421441	journal	May 2004
Specificity of interactions of galectin-3 with Chrp, a cysteine- and histidine-rich cytoplasmic protein Bawumia, Sulemana; Barboni, Eminia A. M.; Menon, Rajesh P. Biochimie, Vol. 85, Issue 1-2, p. 189-194 https://doi.org/10.1016/S0300-9084(03)00007-5	journal	February 2003
Oncostatin M Regulates the Synthesis and Turnover of gp130, Leukemia Inhibitory Factor Receptor α, and Oncostatin M Receptor β by Distinct Mechanisms Blanchard, Frédéric; Wang, Yanping; Kinzie, Erin Journal of Biological Chemistry, Vol. 276, Issue 50, p. 47038-47045 https://doi.org/10.1074/jbc.M107971200	journal	October 2001
Inflammatory Markers and Platelet Aggregation Tests as Predictors of Hemoglobin and Endogenous Erythropoietin Levels in Hemodialysis Patients Borawski, Jacek; Pawlak, Krystyna; Myśliwiec, Michał Nephron, Vol. 91, Issue 4, p. 671-681 https://doi.org/10.1159/000065030	journal	January 2002
Expression of short-form oncostatin M receptor as a decoy receptor in lung adenocarcinomas Chen, D. R.; Chu, C-Y.; Chen, C-Y. The Journal of Pathology, Vol. 215, Issue 3, p. 290-299 https://doi.org/10.1002/path.2361	journal	July 2008
Model Predictive Control of Erythropoietin Administration in the Anemia of ESRD Gaweda, Adam E.; Jacobs, Alfred A.; Aronoff, George R. American Journal of Kidney Diseases, Vol. 51, Issue 1, p. 71-79 https://doi.org/10.1053/j.ajkd.2007.10.003	journal	January 2008
Role of cytokines in the response to erythropoietin in hemodialysis patients Goicoechea, Marian; Martin, Julio; de Sequera, Patricia Kidney International, Vol. 54, Issue 4, p. 1337-1343 https://doi.org/10.1046/j.1523-1755.1998.00084.x	journal	October 1998
Soluble Erythropoietin Receptor Contributes to Erythropoietin Resistance in End-Stage Renal Disease Khankin, Eliyahu V.; Mutter, Walter P.; Tamez, Hector PLoS ONE, Vol. 5, Issue 2, Article No. e9246 https://doi.org/10.1371/journal.pone.0009246	journal	February 2010
Precision proteomics: The case for high resolution and high mass accuracy Mann, M.; Kelleher, N. L. Proceedings of the National Academy of Sciences, Vol. 105, Issue 47, p. 18132-18138 https://doi.org/10.1073/pnas.0800788105	journal	September 2008
Cellular Cholesterol Depletion Triggers Shedding of the Human Interleukin-6 Receptor by ADAM10 and ADAM17 (TACE) Matthews, Vance; Schuster, Björn; Schütze, Stefan Journal of Biological Chemistry, Vol. 278, Issue 40, p. 38829-38839 https://doi.org/10.1074/jbc.M210584200	journal	June 2003
Signals for stress erythropoiesis are integrated via an erythropoietin receptor-phosphotyrosine-343-Stat5 axis Menon, Madhu P.; Karur, Vinit; Bogacheva, Olga Journal of Clinical Investigation, Vol. 116, Issue 3, p. 683-694 https://doi.org/10.1172/JCI25227	journal	March 2006
Interaction of a novel cysteine and histidine-rich cytoplasmic protein with galectin-3 in a carbohydrate-independent manner Menon, Rajesh P.; Strom, Molly; Hughes, R. Colin FEBS Letters, Vol. 470, Issue 3, p. 227-231 https://doi.org/10.1016/S0014-5793(00)01310-7	journal	March 2000
Proteomic analysis of renal calculi indicates an important role for inflammatory processes in calcium stone formation Merchant, Michael L.; Cummins, Timothy D.; Wilkey, Daniel W. American Journal of Physiology-Renal Physiology, Vol. 295, Issue 4, p. F1254-F1258 https://doi.org/10.1152/ajprenal.00134.2008	journal	October 2008
Dual Oncostatin M (OSM) Receptors: Cloning And Characterization Of An Alternative Signaling Subunit Conferring OSM-Specific Receptor Activation Mosley, Bruce; De Imus, Cyr; Friend, Della Journal of Biological Chemistry, Vol. 271, Issue 51, p. 32635-32643 https://doi.org/10.1074/jbc.271.51.32635	journal	December 1996
IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin Nemeth, Elizabeta; Rivera, Seth; Gabayan, Victoria Journal of Clinical Investigation, Vol. 113, Issue 9, p. 1271-1276 https://doi.org/10.1172/JCI200420945	journal	May 2004
Targeted disruption of oncostatin M receptor results in altered hematopoiesis Tanaka, Minoru; Hirabayashi, Yoko; Sekiguchi, Takashi Blood, Vol. 102, Issue 9, p. 3154-3162 https://doi.org/10.1182/blood-2003-02-0367	journal	November 2003
Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure van der Putten, Karien; Braam, Branko; Jie, Kim E. Nature Clinical Practice Nephrology, Vol. 4, Issue 1, p. 47-57 https://doi.org/10.1038/ncpneph0655	journal	January 2008
Hypoxia-inducible factor 1α is up-regulated by oncostatin M and participates in oncostatin M signaling Vollmer, Stefan; Kappler, Valérie; Kaczor, Jakub Hepatology, Vol. 50, Issue 1, p. 253-260 https://doi.org/10.1002/hep.22928	journal	March 2009
Secondary analysis of the CHOIR trial epoetin-α dose and achieved hemoglobin outcomes Szczech, Lynda A.; Barnhart, Huiman X.; Inrig, Jula K. Kidney International, Vol. 74, Issue 6, p. 791-798 https://doi.org/10.1038/ki.2008.295	journal	September 2008
Epoetin requirements predict mortality in hemodialysis patients Zhang, Yi; Thamer, Mae; Stefanik, Kevin American Journal of Kidney Diseases, Vol. 44, Issue 5 https://doi.org/10.1053/j.ajkd.2004.08.002	journal	November 2004

Similar Records

Methods and kits for predicting a response to an erythropoietic agent

Patent · Tue Aug 07 00:00:00 EDT 2018 · OSTI ID:1184560

Merchant, Michael L.; Klein, Jon B.; Brier, Michael E.; +1 more

Enzyme-linked immunosorbent assay for detection of organophosphorylated butyrylcholinesterase: A biomarker of exposure to organophosphate agents

Journal Article · Thu May 05 00:00:00 EDT 2011 · Analytica Chimica Acta, 693(1-2):1-6 · OSTI ID:1184560

Wang, Liming; Du, Dan; Lu, Donglai; +6 more

Semiquantitative measure of immune responses against erythropoietic stem cell antigens

Journal Article · Thu Jan 01 00:00:00 EST 1987 · Immunogenetics (N.Y.); (United States) · OSTI ID:1184560

Harrison, D E

Related Subjects

60 APPLIED LIFE SCIENCES
59 BASIC BIOLOGICAL SCIENCES

Title: Methods and kits for predicting a response to an erythropoietic agent

Citation Formats

References (30)

Similar Records

Related Subjects